WHO ICTRP trial
SAS115359, a Safety and Efficacy Study of Inhaled Fluticasone…
NL-OMON37915 · Overview of Medical Research in the Netherlands (NL-OMON)
Key facts
| Trial ID | NL-OMON37915 |
|---|---|
| Public title | SAS115359, a Safety and Efficacy Study of Inhaled Fluticasone Propionate/Salmeterol Combination versus Inhaled Fluticasone Propionate in the Treatment of Adolescent and Adult Subjects with Asthma. |
| Scientific title | SAS115359, a Safety and Efficacy Study of Inhaled Fluticasone Propionate/Salmeterol Combination versus Inhaled Fluticasone Propionate in the Treatment of Adolescent and Adult Subjects with Asthma. - AUSTRI |
| Primary sponsor | GlaxoSmithKline Research & Development Limited |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Study type | Interventional |
| Phase | 4 |
| Countries | Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Finland;France;Germany;Hong Kong;Hungary;India;Indonesia;Israel;Italy;Japan;Korea (the Republic… |
| Conditions | asthma;10038716;asthma |
| Interventions | Subjects administer inhalation twice daily of one of the doses (FP 100mcg, FP 250 mgc, FSC 100/50mcg, FSC 250/50 mcg of FSC 500/50 mgc) ;asthma;fluticasone propionate;salmetarol;treatment |
| Registration date | Aug 23, 2012 |
| Target size | 50 |
| Secondary IDs | 2011-001644-29;NCT01475721;NL39428.075.12 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: